Berlin - Delayed Quote EUR
AbCellera Biologics Inc (8QQ.BE)
2.5800
-0.1940
(-6.99%)
At close: June 13 at 8:08:05 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-78,402
-108,556
-43,877
277,360
244,584
Investing Cash Flow
99,434
121,409
-221,108
-352,625
-332,247
Financing Cash Flow
15,908
12,769
10,356
-1,628
-3,886
End Cash Position
187,802
183,615
160,610
414,650
501,142
Capital Expenditure
-64,892
-78,396
-77,507
-72,660
-58,452
Issuance of Capital Stock
--
--
--
0
0
Issuance of Debt
--
--
11,590
2,755
5,487
Repayment of Debt
--
--
--
-323
-1,823
Free Cash Flow
-143,294
-186,952
-121,384
204,700
186,132
12/31/2021 - 12/23/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GXE.F Galapagos NV
24.76
+0.08%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
AB3A.MU Sarepta Therapeutics Inc
31.82
-1.18%
ITRX inTerra Resources Corp
0.0240
0.00%
GENSY Genus plc
24.34
0.00%
ONCIN.OL Oncoinvent ASA
1.8500
-8.64%
AYJ.HA Valneva SE
2.6180
-4.10%
300759.SZ Pharmaron Beijing Co., Ltd.
24.84
-2.47%
T3X.BE Telix Pharmaceuticals Ltd
13.93
-5.63%
BCX.WA Bioceltix S.A.
111.20
-2.46%